Scarica l'app Stockscreener
14.71
8.50%
1.125
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.58
Aprire:
$13.58
Volume 24 ore:
150.57K
Relative Volume:
0.46
Capitalizzazione di mercato:
$273.46M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-18.38
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
-2.94%
1M Prestazione:
-25.74%
6M Prestazione:
+26.91%
1 anno Prestazione:
+228.15%
Intervallo 1D:
$13.58
$14.82
Intervallo di 1 settimana:
$13.57
$15.10
Portata 52W:
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Confronta OPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
14.67 | 253.14M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
242.57 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
69.20 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
102.51 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.30 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.66 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - Defense World
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - Nasdaq
OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat
When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Published on: 2025-11-16 12:30:34 - newser.com
Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Can a trend reversal in OptimizeRx Corporation lead to recoveryJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ETFs Investing in OptimizeRx Corporation Stocks - TradingView
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Citizens Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts - Yahoo Finance
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates - sharewise.com
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
[10-Q] OptimizeRx Corp Quarterly Earnings Report | OPRX SEC FilingForm 10-Q - Stock Titan
OptimizeRx (OPRX) Analyst Rating Update: Price Target Raised to $24.00 | OPRX Stock News - GuruFocus
OptimizeRx Delivers Big Earnings Beat And Raises Outlook Again - Finimize
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... By GuruFocus - Investing.com Canada
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... - Yahoo Finance
Vanguard Group Inc's Strategic Acquisition of OptimizeRx Corp Sh - GuruFocus
Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations - Investing.com
OPTIMIZERx earnings beat by $0.16, revenue topped estimates - Investing.com
OptimizeRx Corp reports results for the quarter ended September 30Earnings Summary - TradingView
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance - The Manila Times
[8-K] OptimizeRx Corp Reports Material Event | OPRX SEC FilingForm 8-K - Stock Titan
OptimizeRx (Nasdaq: OPRX) raises full-year outlook to $105M-$109M; updates EBITDA view - Stock Titan
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Optimizerx Corp Azioni (OPRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
10.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):